BLASTICON BIOTECH FORSCHUNG has a total of 41 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ARTECEL SCIENCES INC, MINA THERAPEUTICS LTD and ASTELLAS INST OF REGENERATIVE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 5 | |
#3 | Israel | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Brazil | 3 | |
#6 | China | 3 | |
#7 | Hong Kong | 3 | |
#8 | Canada | 2 | |
#9 | Norway | 2 | |
#10 | Argentina | 1 | |
#11 | Australia | 1 | |
#12 | Germany | 1 | |
#13 | Jordan | 1 | |
#14 | Japan | 1 | |
#15 | Republic of Korea | 1 | |
#16 | Poland | 1 | |
#17 | Taiwan | 1 | |
#18 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kremer Bernd Karl Friedrich | 30 |
#2 | Faendrich Fred | 24 |
#3 | Ruhnke Maren | 17 |
#4 | Schulze Maren | 12 |
#5 | Fandrich Fred | 6 |
#6 | Fondrich Fred | 3 |
#7 | Ruhnke Maren Nee Schulze | 3 |
#8 | Maren Kremer Bernd Karl Friedr | 2 |
#9 | Fred Faendrich | 1 |
#10 | Kremer Bernd K F | 1 |
Publication | Filing date | Title |
---|---|---|
CA2531627A1 | Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations | |
TW200411059A | Dedifferentiated, programmable stem cells of monocytic origin, and their production and use | |
WO03083091A1 | Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof | |
DE10231655A1 | Graft acceptance-inducing cells of monocytic origin, as well as their production and use |